These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19610068)

  • 21. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of axin and β-catenin protein expression in primary hepatocellular carcinomas.
    Guan CN; Chen XM; Lou HQ; Liao XH; Chen BY; Zhang PW
    Asian Pac J Cancer Prev; 2012; 13(2):677-81. PubMed ID: 22524844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas.
    Ihara A; Koizumi H; Hashizume R; Uchikoshi T
    Hepatology; 1996 Jun; 23(6):1441-7. PubMed ID: 8675162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
    Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
    Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
    Yang L; Hu B; Zhang Y; Qiang S; Cai J; Huang W; Gong C; Zhang T; Zhang S; Xu P; Wu X; Liu J
    Med Oncol; 2015 Apr; 32(4):128. PubMed ID: 25794490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.
    Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL
    Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
    Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
    Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S
    Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis.
    Liu Q; Zhou C; Zhang B
    BMC Gastroenterol; 2019 Dec; 19(1):230. PubMed ID: 31888604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
    Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
    Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
    Feitelson MA; Duan LX
    Am J Pathol; 1997 Apr; 150(4):1141-57. PubMed ID: 9094970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
    Wang WL; London WT; Feitelson MA
    Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.
    Tufan NL; Lian Z; Liu J; Pan J; Arbuthnot P; Kew M; Clayton MM; Zhu M; Feitelson MA
    Neoplasia; 2002; 4(4):355-68. PubMed ID: 12082552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.
    Nhieu JT; Renard CA; Wei Y; Cherqui D; Zafrani ES; Buendia MA
    Am J Pathol; 1999 Sep; 155(3):703-10. PubMed ID: 10487827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
    Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
    J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.